Detection of platelet-activating factor in gingival tissue surrounding failed dental implants

Journal of Periodontology

Volumn 72, Issue 1, 2001, Pages 57-64

  Bassi, Francesco ^a   Marchisella, Cristiano ^a   Schierano, Gianmario ^a   Gasser, Egon ^a   Montrucchio, Giuseppe ^d   Valente, Guido ^b   Camussi, Giovanni ^d   Preti, Giulio ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c Dipto di Fisiopatologia Clinica   (Italy)

^d NONE

Author keywords

Dental implants; Dental implants failure; Osseointegration; Platelet activating factor

Indexed keywords

AUTACOID; COLORING AGENT; DIAGNOSTIC AGENT; LIPID; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ARTICLE; BONE REGENERATION; CHEMISTRY; DENTAL SURGERY; FEMALE; FOLLOW UP; GINGIVA; GINGIVITIS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MALE; MAST CELL; METABOLISM; MICROCIRCULATION; MIDDLE AGED; MOUTH DISEASE; NONPARAMETRIC TEST; PATHOLOGY; PLASMA CELL; TOOTH IMPLANTATION; VASCULARIZATION;

ADULT; AGED; COLORING AGENTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; FEMALE; FOLLOW-UP STUDIES; GINGIVA; GINGIVITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; LIPIDS; LYMPHOCYTES; MACROPHAGES; MALE; MAST CELLS; MICROCIRCULATION; MIDDLE AGED; MOUTH, EDENTULOUS; OSSEOINTEGRATION; PLASMA CELLS; PLATELET ACTIVATING FACTOR; STATISTICS, NONPARAMETRIC;

EID: 0035220231     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.1.57     Document Type: Article

References (50)

1. Tonetti MS, Schmid J. Pathogenesis of implant failures. Periodontol 2000 1994;4:127-138.
2. Mombelli A. Microbiology of the dental implant. Adv Dent Res 1993;7:202-206.
3. Schou S, Holmstrup P, Hjørting-Hansen E, Lang NP. Plaque-induced marginal tissue reactions of osseointegrated oral implants: A review of the literature. Clin Oral Implants Res 1992;3:149-161.
4. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I) Success criteria and epidemiology. Eur J Oral Sci 1998;106:527-551.
5. Adell R, Lekholm U, Rockler B, et al. Marginal tissue reactions at osseointegrated titanium fixtures. (I). A 3-year longitudinal prospective study. Int J Oral Maxillofac Surg 1986;15:39-52.
6. Lekholm U, Adell R, Lindhe J, et al. Marginal tissue reactions at osseointegrated titanium fixtures. (II). A cross-sectional retrospective study. Int J Oral Maxillofac Surg 1986;15:53-61.
7. Seymour GJ, Gemmell E, Lenz LJ, Henry P, Bower R, Yamazaki K. Immunohistologic analysis of the inflammatory infiltrates associated with osseointegrated implants. Int J Oral Maxillofac Impl 1989;4:191-198.
8. Lindemann RA, Economou JS, Rothermel H. Production of interleukin-1 and tumor necrosis factor by human peripheral monocytes activated by periodontal bacteria and extracted lipopolysaccharides. J Dent Res 1988;67: 1131-1135.
9. Saglie FR, Simon K, Merrill J, Koeffler HP. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates macrophages to produce interleukin-1 and tumor necrosis factor mRNA and protein. Oral Microbiol Immunol 1990;5:256-262.
10. Bom-van Noorloos AA, van der Meer JWM, van de Gevel JS, Schephens E, van Steenbergen TJM, Burger EH. Bacteroides gingivalis stimulates bone resorption via interleukin-1 production by mononuclear cells. J Clin Periodontol 1990;17:409-413.
11. Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T. Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin 1. J Immunol 1985;135:2562-2568.
12. Salvi GE, Brown CE, Fujihashi K, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodont Res 1998;33:212-225.
13. Dongari-Bagtzoglou Al, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast sub-populations in adult periodontitis. J Periodontol 1998;69: 899-910.
14. Gainet J, Chollet-Martin S, Brion M, Hakim J, Gougerot-Pocidalo MA, Elbim C. Interleukin-8 production by polymorphonuclear neutrophils in patients with rapidly progressive periodontitis: An amplifying loop of polymorphonuclear neutrophil activation. Lab Invest 1998; 78:755-762.
15. 2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun 1987;55:2148-2154.
16. Bertolini DR, Nedwin G, Bringman T, Smith D, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by tumor necrosis factor (TNF). Nature 1986;319:516-518.
17. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-779.
18. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ. Gingival fibroblasts degrade type 1 collagen films when stimulated with tumor necrosis factor and interleukin-1: Evidence that the breakdown is mediated by metalloproteinases. J Periodont Res 1989;24:207-213.
19. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991;26:230-242.
20. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993; 28:500-510.
21. Lerner UH, Modeer T, Krekmanova L, Claesson R, Rasmussen L. Gingival crevicular fluid from patients with periodontitis contains bone resorbing activity. Eur J Oral Sci 1998;106:778-787.
22. Leaver HA, Smith S, Howei A, Ross WB, Yap PL. Endotoxin releases platelet-activating factor from human monocytes in vitro. Immunopharmacol 1990;20:105-113.
23. Camussi G, Mariano F, Biancone L, et al. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 1995;155:316-324.
24. Shaw JO, Pinckard RN, Ferrigni KS, McManus LM, Hanahan DJ. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3phosphorylcoline (platelet activating factor). J Immunol 1981;127:1250-1255.
25. Camussi G, Tetta C, Bussolino F, et al. Mediators of immune complex induced aggregation of polymorphonuclear neutrophils. PAF as the effector substance of immune induced aggregation. Int Arch Allergy Appl Immunol 1981;64:25-41.
26. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 1992;13:93-100.
27. Montrucchio G, Lupia E, Battaglia E, et al. Tumor necrosis factor-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994; 180:377-382.
28. Camussi G, Montrucchio G, Lupia E, et al. Platelet activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995;154: 6492-6501.
29. Zheng ZG, Wood DA, Sims SM, Dixon SJ. Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro. Am J Physiol 1993;264(Pt. 1):E74-E81.
30. Cox CP, Wardlow ML, Jorgensen R, Farr RS. The presence of platelet-activating factor (PAF) in normal human mixed saliva. J Immunol 1981;127:46-50.
31. McManus LM, Marze BT, Schless AV. Deficiency of salivary PAF in edentulous individuals. J Periodont Res 1990;25:347-351.
32. Garito ML, Prihoda TJ, McManus LM. Salivary PAF levels correlate with the severity of periodontal inflammation. J Dent Res 1995;74:1048-1056.
33. Noguchi K, Morita I, Murota S. The detection of platelet-activating factor in the inflamed human gingival tissue. Arch Oral Biol 1989;34:37-41.
34. Rasch MS, Mealey BL, Prihoda TJ, Woodard DS, McManus LM. The effect of initial periodontal therapy on salivary PAF levels in chronic adult periodontitis. J Periodontol 1995;66:613-623.
35. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37: 911-917.
36. Pinckard RN, Farr RS, Hanahan DJ. Physicochemical and functional identity of rabbit platelet-activating factor released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol 1979;123:1847-1857.
37. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet-activating factor. J Pharmacol Exp Ther 1990;255:962-968.
38. Montrucchio G, Bergerone S, Bussolino F, et al. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation 1993;88:1476-1483.
39. Bussolino F, Arese M, Silvestro L, et al. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor alpha or interleukin-1 alpha. Eur J Immunol 1994;24:3131-3139.
40. Benveniste J, LeCouedic J, Polonsky J, Tencé M. Structural analysis of purified platelet-activating factor by lipases. Nature 1977;269:1570-1591.
41. McManus LM, Woodard DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: Pathobiological implications. Lab Invest 1993;69:639-650.
42. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990;43: 752-757.
43. Seymour GJ. Possible mechanisms involved in the immunoregulation of chronic inflammatory periodontal disease. J Dent Res 1987;66:2-9.
44. Ranney RR. Immunologic mechanisms of pathogenesis in periodontal diseases: An assessment. J Periodont Res 1991;26:243-254.
45. Howells GL. Cytokine networks in destructive periodontal disease. Oral Dis 1995;1:266-270.
46. Yoneda T. Cytokines in bone. Local translators in cell-to-cell communications. In: Noda M, ed. Cellular and Molecular Biology of Bone. San Diego: Academic Press; 1993:375-412.
47. Yoneda T, Kato I, Bonewald LF, Burgess WH, Mundy GR. A novel cytokine with osteoclastic activity. J Periodont Res 1993;28:521-522.
48. Camussi G, Tetta C, Baglioni C. The role of platelet-activating factor in inflammation. Short analytical review. Clin Immun Immunopathol 1990;57:331-338.
49. Bussolino F, Arese M, Montrucchio G, et al. Platelet-activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995;96:940-952.
50. Folkman J. Regulation of angiogenesis: A new function of heparin. Biochem Pharmacol 1985;34:905-909.